257 related articles for article (PubMed ID: 15723079)
21. A stable chemical SUMO1-Ubc9 conjugate specifically binds as a thioester mimic to the RanBP2-E3 ligase complex.
Sommer S; Ritterhoff T; Melchior F; Mootz HD
Chembiochem; 2015 May; 16(8):1183-9. PubMed ID: 25917782
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a novel posttranslational modification in neuronal nitric oxide synthase by small ubiquitin-related modifier-1.
Watanabe M; Itoh K
Biochim Biophys Acta; 2011 Jul; 1814(7):900-7. PubMed ID: 21545853
[TBL] [Abstract][Full Text] [Related]
23. Structure of ubiquitin-conjugating enzyme 9 displays significant differences with other ubiquitin-conjugating enzymes which may reflect its specificity for sumo rather than ubiquitin.
Giraud MF; Desterro JM; Naismith JH
Acta Crystallogr D Biol Crystallogr; 1998 Sep; 54(Pt 5):891-8. PubMed ID: 9757105
[TBL] [Abstract][Full Text] [Related]
24. Identification of SUMO-conjugated proteins and their SUMO attachment sites using proteomic mass spectrometry.
Wohlschlegel JA
Methods Mol Biol; 2009; 497():33-49. PubMed ID: 19107409
[TBL] [Abstract][Full Text] [Related]
25. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of E1-E2 interaction for the inhibition of Ubl adenylation.
Wang J; Cai S; Chen Y
J Biol Chem; 2010 Oct; 285(43):33457-33462. PubMed ID: 20682785
[TBL] [Abstract][Full Text] [Related]
27. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
[TBL] [Abstract][Full Text] [Related]
28. Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs).
Wu YC; Roark AA; Bian XL; Wilson VG
Virology; 2008 Sep; 378(2):329-38. PubMed ID: 18619639
[TBL] [Abstract][Full Text] [Related]
29. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
[TBL] [Abstract][Full Text] [Related]
30. E2-25K mediates US11-triggered retro-translocation of MHC class I heavy chains in a permeabilized cell system.
Flierman D; Coleman CS; Pickart CM; Rapoport TA; Chau V
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11589-94. PubMed ID: 16868077
[TBL] [Abstract][Full Text] [Related]
31. SUMO protein modification.
Dohmen RJ
Biochim Biophys Acta; 2004 Nov; 1695(1-3):113-31. PubMed ID: 15571812
[TBL] [Abstract][Full Text] [Related]
32. Interaction between
Yi J; Wang Y; Li Q; Zhang H; Shao Z; Deng X; He J; Xiao C; Wang Z; Wang Y; Chen C
J Vet Sci; 2019 Sep; 20(5):e54. PubMed ID: 31565897
[No Abstract] [Full Text] [Related]
33. Sumoylation of a meiosis-specific RecA homolog, Lim15/Dmc1, via interaction with the small ubiquitin-related modifier (SUMO)-conjugating enzyme Ubc9.
Koshiyama A; Hamada FN; Namekawa SH; Iwabata K; Sugawara H; Sakamoto A; Ishizaki T; Sakaguchi K
FEBS J; 2006 Sep; 273(17):4003-12. PubMed ID: 16879611
[TBL] [Abstract][Full Text] [Related]
34. SUMO Ubc9 enzyme as a viral target.
Varadaraj A; Mattoscio D; Chiocca S
IUBMB Life; 2014 Jan; 66(1):27-33. PubMed ID: 24395713
[TBL] [Abstract][Full Text] [Related]
35. Iodination of tyrosine 59 of ubiquitin selectively blocks ubiquitin's acceptor activity in diubiquitin synthesis catalyzed by E2(25K).
Pickart CM; Haldeman MT; Kasperek EM; Chen Z
J Biol Chem; 1992 Jul; 267(20):14418-23. PubMed ID: 1321147
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for SUMO-E2 interaction revealed by a complex model using docking approach in combination with NMR data.
Ding H; Yang Y; Zhang J; Wu J; Liu H; Shi Y
Proteins; 2005 Dec; 61(4):1050-8. PubMed ID: 16224784
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases.
de Pril R; Fischer DF; Roos RA; van Leeuwen FW
Mol Cell Neurosci; 2007 Jan; 34(1):10-9. PubMed ID: 17092742
[TBL] [Abstract][Full Text] [Related]
38. Role of two residues proximal to the active site of Ubc9 in substrate recognition by the Ubc9.SUMO-1 thiolester complex.
Tatham MH; Chen Y; Hay RT
Biochemistry; 2003 Mar; 42(11):3168-79. PubMed ID: 12641448
[TBL] [Abstract][Full Text] [Related]
39. Structure and analysis of a complex between SUMO and Ubc9 illustrates features of a conserved E2-Ubl interaction.
Capili AD; Lima CD
J Mol Biol; 2007 Jun; 369(3):608-18. PubMed ID: 17466333
[TBL] [Abstract][Full Text] [Related]
40. Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1.
Lois LM; Lima CD
EMBO J; 2005 Feb; 24(3):439-51. PubMed ID: 15660128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
